Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
FOXO4-DRI Key Research Facts Full name: FOXO4 D-Retro-Inverso peptide (FOXO4-DRI) Classification: Cell-penetrating senolytic peptide FOXO4/p53 protein-protein interaction inhibitor Design: D-retro-inverso isoform of FOXO4s p53-binding domain reversed sequence with all D-amino acids Binding target: p53 transactivation domain 2 (TAD2) displaces FOXO4 from the FOXO4-p53 complex Mechanism: FOXO4-DRI binds p53 TAD2 p53 nuclear exclusion p53 mitochondrial translocation BAX activation caspase-3 cleavage senescent cell-selective apoptosis Selectivity basis: FOXO4 is upregulated in senescent cells but expressed at low levels in most non-senescent adult cells selectivity is mechanistically conferred D-amino acid advantage: Proteolytic stability resistant to intracellular peptidases that would rapidly degrade equivalent L-amino acid sequences Structural characterisation: NMR structural models of FOXO4-DRI/p53TAD2 complex resolved (Nature Communications, 2025) confirms disordered-to-ordered transition upon binding Research cell types studied: IMR90 fibroblasts, TM3 Leydig cells, endothelial cells, chondrocytes, keloid fibroblasts, HCT116 cancer cells In vitro working concentration: 25 M used in multiple published studies for senescent cell apoptosis induction What Does FOXO4-DRI Do in Research
Mild reactions seen in oral CBD studies include the following: Digestive problems like diarrhea, nausea, vomiting, constipation, stomach pain, and bloating Fatigue Changes in appetite Headaches Weight changes (gain or loss) Skin irritation Sleep problems like insomnia Dizziness or lightheadedness Fever Less common but serious complications of oral CBD include liver stress, producing abnormal liver function test results
Disrupting the FOXO4-p53 interaction induces p53 nuclear exclusion, leading to apoptosis in senescent cells while sparing healthy ones
TSH, Thyroid stimulating hormone
US$ 22.61
US$ 21.80
US$ 21.29
US$ 22.37
